Navigation Links
Anaptys Biosciences Raises Over $33 Million in Series B Financing
Date:11/8/2007

New Capital to Support Continued Advancement of Novel Technology and

Product Portfolio

LA JOLLA, Calif., Nov. 8 /PRNewswire/ -- Anaptys Biosciences, Inc., a privately-held therapeutic antibody product company, today announced that it has raised $33.9 million in a Series B equity financing led by Novo A/S. Additional investors participating significantly in the round were Frazier Healthcare Ventures and Alloy Ventures, along with founding investor Avalon Ventures. Completing the syndicate were Numenor Ventures, WS Investment Company, and Anaptys board member, Dr. Nick Lydon.

The new investment capital will support continued advancement of the company's novel technology for therapeutic antibody discovery and optimization, and building a pipeline of product candidates.

"We are pleased to have attracted such a strong investor group to support the company's multiple development programs," said Tom Smart, chairman and chief executive officer of Anaptys. "In addition to providing significant financial resources, these experienced investors bring Anaptys a wealth of operational, medical, and industry expertise along with key relationships that will serve the company well during this important stage of growth and achievement."

In connection with the financing, Heath Lukatch, Ph.D., of Novo A/S, James N. Topper, M.D., Ph.D., of Frazier Healthcare Ventures, and J. Leighton Read, M.D., of Alloy Ventures will join the Anaptys Board of Directors together with existing members Kevin J Kinsella of Avalon Ventures, Nick Lydon, Ph.D., of Granite Biopharma, LLC, R. Scott Greer of Numenor Ventures, and Anaptys executives William Boyle, Ph.D., and Tom Smart.

"It is a great pleasure for Novo A/S to lead this investment in Anaptys," said Dr. Lukatch. "The company has developed powerful technologies to quickly and cost effectively optimize antibodies against a variety of high value targets. By harnessing the efficiency of
'/>"/>

SOURCE Anaptys Biosciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Sangamo BioSciences to Present at the ThinkEquity Partners Growth Conference
2. Akers Biosciences, Inc. ABI or the Company Receipt of Further United States Military Contracts
3. Pressure BioSciences to Present at the Rodman & Renshaw BioFin 9th Annual Healthcare Conference in New York City on November 5th
4. Neurocrine Biosciences to Present at the CIBC World Markets 18th Annual Healthcare Conference
5. Pressure BioSciences, Inc. to Discuss Third Quarter Financial Results and Provide Business Update
6. Monogram Biosciences to Present at The Lazard Capital Markets Fourth Annual Healthcare Conference
7. BlueCare(R) Family Plan, a HUSKY Health Plan from Anthem Blue Cross and Blue Shield in Connecticut, Raises Awareness, Funds and Diapers for New Haven Diaper Bank
8. Nautica Malibu Triathlon Presented by Toyota Raises $718,000 for Childrens Hospital Los Angeles Pediatric Cancer Research
9. Fifth Annual Avon Walk for Breast Cancer Los Angeles Raises $4.3 Million
10. AHIP Praises Bipartisan Senate Vote on Mental Health Parity
11. Union President Praises Hillary Clintons Health Plan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/22/2014)... MD, April 22, 2014: The Association for Molecular ... The Journal of Molecular Diagnostics on recommendations ... baccalaureate and master,s levels of education. The report ... Curriculum Task Force of the AMP Training and ... critical need of educating future medical laboratory scientists ...
(Date:4/22/2014)... German . ... but their mode of action is complex: In low ... behavior, while at high concentrations they can cause "oxidative ... how redox signaling unfolds in single cells and organelles ... developed jointly by the teams of LMU Professor Martin ...
(Date:4/22/2014)... we all seem to know who we say is neurotic ... isn,t unable to act but simply doesn,t want to., ... study of nearly 4,000 college students in 19 countries has ... decisions and moving forward with life. Turns out that when ... just don,t like it as much as non-neurotics. Therefore persuasive ...
(Date:4/22/2014)... This news release is available in German . ... F. Perutz Laboratories of the University of Vienna and the ... Zurich, have now shown how double stranded RNA, such as ... a cell. During the immune response against viral infection, the ... cytoplasm. There it modifies viral RNA to inhibit reproduction of ...
(Date:4/22/2014)... like toddlers, but their total brain size suggests ... or fox squirrel, according to a new study ... from orangutans to zebra finches. , Scientists at ... than two-dozen other research institutions collaborated on this ... defined in the study as the ability to ...
Breaking Medicine News(10 mins):Health News:AMP publishes curriculum recommendations for medical laboratory scientists 2Health News:Neuroimaging: Live from inside the cell 2Health News:Neurotics don't just avoid action: They dislike it 2Health News:How the body fights against viruses 2Health News:How the body fights against viruses 3Health News:Brain size matters when it comes to animal self-control 2Health News:Brain size matters when it comes to animal self-control 3
... MedCom USA, Inc.,(OTC Bulletin Board: EMED), a leading ... for the healthcare industry,has signed a distribution agreement ... force, the product line of MedCom USA.,MedCom,s products ... options which include Credit/Debit, Easy Pay and Check,Guarantee/EFT ...
... Heart Association says high blood sugar condition linked to ... -- A national effort is needed to deal with ... says an American Heart Association scientific statement released Monday. ... about the condition, also known as hyperglycemia, in people ...
... Rigel,Pharmaceuticals, Inc. (Nasdaq: RIGL ) today announced ... president of clinical research. In this newly,created position, ... and,oversight of Rigel,s clinical research programs in rheumatoid ... syk kinase,inhibitor, is expected to enter advanced Phase ...
... /Xinhua-PRNewswire-FirstCall/ -- Lotus,Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS; ... the United States that operates Beijing Liang,Fang Pharmaceutical ... Pharmaceutical,Co., Ltd. both of which are pharmaceutical companies ... that it has raised $5 million in,a private ...
... NEW YORK, Feb. 26 , WHO: New York Lt. Gov. David A. Paterson, along with stem ... R. Lyon, M.D., will be the keynote speakers at the 3rd ... p.m. on Tuesday, February 26 ... Trianon Ballroom 1335 Avenue ...
... BMR, TORONTO, Feb. 26 /PRNewswire-FirstCall/ ... dedicated to the development and,commercialization of ... II data,on the Company,s Neuradiab product ... glioblastoma multiforme (GBM) were published in ...
Cached Medicine News:Health News:MedCom USA Signs Southwood Medical Marketing to Distribute MedCom System 2Health News:MedCom USA Signs Southwood Medical Marketing to Distribute MedCom System 3Health News:MedCom USA Signs Southwood Medical Marketing to Distribute MedCom System 4Health News:National Effort Needed to Address Hyperglycemia in Heart Patients 2Health News:Daniel Magilavy, M.D. Joins Rigel as Vice President of Clinical Research 2Health News:Daniel Magilavy, M.D. Joins Rigel as Vice President of Clinical Research 3Health News:Lotus Pharmaceuticals Raises $5 Million in Private Placement 2Health News:Lotus Pharmaceuticals Raises $5 Million in Private Placement 3Health News:MEDIA ADVISORY: New York Lt. Gov. David Paterson and Stem Cell Experts to Participate in 3rd Annual Stem Cell Summit 2Health News:Bradmer announces Phase II results published in newly diagnosed glioblastoma which demonstrate improved survival and support upcoming Phase III study 2Health News:Bradmer announces Phase II results published in newly diagnosed glioblastoma which demonstrate improved survival and support upcoming Phase III study 3Health News:Bradmer announces Phase II results published in newly diagnosed glioblastoma which demonstrate improved survival and support upcoming Phase III study 4
(Date:1/15/2014)...  Celsion Corporation (the "Company") (NASDAQ: CLSN ) ... investors to purchase an aggregate of approximately $15 million ... direct offering, led by a dedicated health care fund. ... with these investors pursuant to which the Company agreed ...
(Date:1/15/2014)... , Jan. 15, 2014  Manufacturers, suppliers and distributors ... able to protect their most important business assets, ... ) Because of the highly-competitive ... remains one of the most litigious industry sectors ...
(Date:1/15/2014)... , Jan. 15, 2014 The Cadence Fitness ... Fitness Center by the Medical Fitness Association, a non-profit ... achieve their full potential. The Cadence Fitness & Health ... western suburbs and second in the Chicagoland area. ...
Breaking Medicine Technology:Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Intellectual Property Insurance for Medical-related Products and Services 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 3
... help reduce state Medicaid spending, the Obama administration has ... private health plans by 2013. Despite strong opposition from ... modernize the state,s prescription drug benefits to be operated ... and the private sector. Currently the Texas Medicaid program ...
... a commercial stage private oncology company, announced today ... executives to its Global Commercialization Team.  The Global ... new tumor treating fields (TTF) cancer therapy to ... has joined Novocure as chief commercial officer responsible ...
Cached Medicine Technology:Texas to Modernize Medicaid Rx Benefits, Curb Pharmacy Overpayments 2Novocure Adds Three Senior Oncology Executives to its Global Management Team 2Novocure Adds Three Senior Oncology Executives to its Global Management Team 3Novocure Adds Three Senior Oncology Executives to its Global Management Team 4
... The VersaPulse® PowerSuite™ holmium laser combines ... for precise, virtually bloodless procedures. It ... urinary and gall bladder stones of ... multipurpose surgical tool. Because its laser ...
... laser combines excellent cutting, ablation and ... procedures. It is also extremely effective ... stones of all compositions, making it ... its laser light is transmitted through ...
... adjustable height permits optimal leg position for the ... a cast with the foot/ankle at 90 degrees ... the tongue of the stand. Stockinette is pulled ... plaster/fiberglass is used in a routine fashion. The ...
... Techno-Aide provides the highest level of ... quality lead protective eyewear. Consistent ... tolerance allowed. Mfg supervised by Licensed ... lens meet or exceed standards for ...
Medicine Products: